Metabomed
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
81220 Israel One Broadway Fl 14, Cambrid...Phone Number
+972 546727878Website
www.metabomed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Metabomed
MetaboMed is leading the discovery and development of novel drugs that target the unique dependencies identified in cancer cell metabolic pathways. The Company has built its integrated synthetic lethal and metabolomic screening platform based on decades of biochemistry and genetics research performed by its founders. The platform leverages computational biology combined with phenotypic screening approaches to identify and address synthetic lethal drug targets within the context of cancer cell metabolism. The Company's pipeline includes an advanced program with a potent and selective inhibitor of the ACSS2 enzyme, as well as multiple lead compounds addressing novel cancer metabolism targets. MetaboMed is dedicated to building a product pipeline addressing cancer cell metabolic targets to improve the lives of cancer patients. The company operates from its facilities in Yavne, Israel, and offices in Cambridge Massachusetts.Explore more
Metabomed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Metabomed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Metabomed is spiking on competitors!
Earning: See what the market has to say on Metabomed recently announced quarterly report
Metabomed, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Metabomed has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Metabomed
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Metabomed launches new products
Funding: Get notified immidiatlly once Metabomed has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Metabomed had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Metabomed
Find 3 more new buyers
Compare Similar Companies to Metabomed
Compare insights from companies similar to Metabomed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Metabomed is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Metabomed is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Metabomed.
Metabomed financials insights
Gather financial insights about Metabomed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Unspecified
$12.5M
Metabomed Tech Stack
A closer look at the technologies used by Metabomed
See more technologies
Metabomed News & Media
MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer
CAMBRIDGE, Mass. and YAVNE, Israel, Sept. 9, 2020 /PRNewswire/ -- MetaboMed, a biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced the appointment of Ali Fattaey, Ph.D. as its new CEO. Dr. Fattaey brings over 20...Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
YAVNE, Israel and CAMBRIDGE, Massachusetts, Dec. 19, 2019 /PRNewswire/ -- Metabomed, a leading cancer metabolism company completed a financing of $12.5 million bringing the total raised to date to $30 million. The company announced that it has declared a clinical candidate for its...Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
Metabomed, a leading cancer metabolism company completed a financing of $12.5 million bringing the total raised to date to $30 million. The company announced that it has declared a clinical candidate for its first-in-class program targeting the inhibition of the AcetylCoA Short chain Synthase 2 enzyme (ACSS2) in cancers dependent on acetate metabolism.Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Metabomed
Sign Up For FreeTo access detailed company insights
MetaboMed is leading the discovery and development of novel drugs that target the unique dependencies identified in cancer cell metabolic pathways. The Company has built its integrated synthetic lethal and metabolomic screening platform based on decades of biochemistry and genetics research performed by its founders. The platform leverages computat... Read More
